Contents

Search

insulin-like growth factor-binding protein 7 (IGFBP7) & tissue inhibitor of metalloproteinase in urine (NephroCheck)

Indications: - predicts risk of acute renal failure Clinical significance: - accuracy: 76-92% - specificity: 0.5 Notes: - results available in 20 minutes (NephroCheck)

General

urine chemistry test

References

  1. FDA News Release. Sept 5, 2014 FDA allows marketing of the first test to assess risk of developing acute kidney injury. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm412910.htm